Linda C Chang

US Patent:

60675683, May 23, 2000

Filed:

Dec 10, 1996

Appl. No.:

8/762736

Inventors:

Jim Y. Li - San Francisco CA
Linda Y. Chang - Milpitas CA
Robert B. Mann - Foster City CA

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

G06F 1300

US Classification:

709223

Abstract:

Various services within a computer system are automatically set up as users are added to the system through a directory service. A user template is selected that already contains default settings for each of the services available on a system such as e-mail and a web service. Various user templates exist and contain different default settings for each available service depending upon the user. Default settings from each service are copied onto a new user form. Next, default settings from the selected user template are copied to the new user form and override any conflicting default settings from the services. The default settings from the new user form are used to automatically set up and enable each service for the new user. The data from the new user form is copied into a central account database that contains rows of user information, with columns corresponding to a particular service. Each user is automatically enabled for use with available services including an e-mail account and a generated web page.

US Patent:

20150158949, Jun 11, 2015

Filed:

Jun 12, 2013

Appl. No.:

14/407156

Inventors:

- Gaithersburg MD, US
Yihong Yao - Gaithersburg MD, US
Bing Wang - Gaithersburg MD, US
Lorin Roskos - Gaithersburg MD, US
Linda Chang - Gaithersburg MD, US

Assignee:

Medlmmune, LLC - Gaithersburg MD

International Classification:

C07K 16/28
G06N 7/00
G06F 19/00
C12Q 1/68

Abstract:

The disclosure provides methods for treating a subject having a type I IFN-mediated disease or disorder comprising administration of a fixed does of an anti-interferon alpha receptor antibody. The disclosure also provides methods for suppressing a type I interferon (IFN) gene signature (GS) in a subject. In addition, the disclosure provides methods of prognosing or monitoring disease progression in a subject having a type I IFN-mediated disease or disorder, methods of predicting a dosage regimen, methods of identifying a candidate therapeutic agent, methods of identifying a patient as a candidate for a therapeutic agent, and methods of designating a personalized therapy.

Address:

355 1 St UNIT 705, San Francisco, CA 94105

Phone:

(617)9058898

VIN:

WBAWV13527PK49178

Make:

BMW

Model:

INVALID VIN

Year:

2007